Christian Benden
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Christian Benden has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Martin J. Elliott
2 shared publicationsPaul Aurora
2 shared publicationsPauline Whitmore
2 shared publicationsC. M. Owens
1 shared publicationC. Wallis
1 shared publicationCathryn Lloyd
1 shared publication
Latest Publications
- 1 December 2005
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 24 (12) , 2103-2108
Monitoring of Epstein–Barr Viral Load in Pediatric Heart and Lung Transplant Recipients by Real-time Polymerase Chain Reaction
- 1 December 2005
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 24 (12) , 2103-2108
Monitoring of Epstein–Barr Viral Load in Pediatric Heart and Lung Transplant Recipients by Real-time Polymerase Chain Reaction
- Open Access
- 1 November 2005
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 26 (5) , 894-897
The Chrispin–Norman score in cystic fibrosis: doing away with the lateral view
The Chrispin–Norman chest radiograph scoring (CNS) system is widely used to assess respiratory disease progression in cystic fibrosis (CF). Frontal and lateral chest radiographs were performed. The present authors developed a modified CNS, which obviates the need for the lateral film. This study compares the original and the current authors' modified scoring system.A total of 50 chest radiographs from CF children, taken between August and December 2003, were scored according to the original and modified CNS. Two observers scored all 50 chest radiographs, scoring in random order the frontal radiographs, and separately the frontal and lateral radiographs together.There was no evidence of a difference between the methods for either observer, using the Bland and Altman 95% limits of agreement as follows: observer 1 (−2.0–1.9), and observer 2 (−1.77–2.2). No evidence of a difference between the observers for either method was found, comparing the 95% limits of agreement (−5.5–5.7) with the modified CNS (−5.6–6.4).In conclusion, in terms of the final score, good agreement was found between the use of the original and modified Chrispin–Norman score. In addition, low inter-observer variability was shown for both methods. The use of the modified Chrispin–Norman chest radiograph scoring system to stage disease severity in cystic fibrosis removes the need for a lateral chest radiograph.
- 1 November 2005
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 26 (5) , 894-897
Open AccessThe Chrispin–Norman score in cystic fibrosis: doing away with the lateral view
The Chrispin–Norman chest radiograph scoring (CNS) system is widely used to assess respiratory disease progression in cystic fibrosis (CF). Frontal and lateral chest radiographs were performed. The present authors developed a modified CNS, which obviates the need for the lateral film. This study compares the original and the current authors' modified scoring system.A total of 50 chest radiographs from CF children, taken between August and December 2003, were scored according to the original and modified CNS. Two observers scored all 50 chest radiographs, scoring in random order the frontal radiographs, and separately the frontal and lateral radiographs together.There was no evidence of a difference between the methods for either observer, using the Bland and Altman 95% limits of agreement as follows: observer 1 (−2.0–1.9), and observer 2 (−1.77–2.2). No evidence of a difference between the observers for either method was found, comparing the 95% limits of agreement (−5.5–5.7) with the modified CNS (−5.6–6.4).In conclusion, in terms of the final score, good agreement was found between the use of the original and modified Chrispin–Norman score. In addition, low inter-observer variability was shown for both methods. The use of the modified Chrispin–Norman chest radiograph scoring system to stage disease severity in cystic fibrosis removes the need for a lateral chest radiograph.
- 4 May 2005
- Published by Wiley in Pediatric Pulmonology
- Vol. 40 (1) , 68-71
High prevalence of gastroesophageal reflux in children after lung transplantation
Bronchiolitis obliterans and its clinical correlate bronchiolitis obliterans syndrome (BOS) are a major cause of morbidity and mortality following lung transplantation. Gastroesophageal reflux disease (GERD) may be a contributing factor for the development of BOS. Since 2002, all recipients of lung and heart‐lung transplantation at our institution have been routinely investigated for GERD. In this observational study, we report on the prevalence of GERD in this population, including all pediatric patients undergoing single (SLTx) or double (DLTx) lung transplantation or heart‐lung (HLTx) transplantation from January 2003–May 2004. GERD was assessed 3–6 months after transplantation by 24‐hr pH testing. The fraction time (Ft) with a pH < 4 within a 24‐hr period was recorded. Spirometry data, episodes of confirmed acute rejection, and demographic data were also collected. Ten transplant operations were performed: 4 DLTx, 1 SLTx, and 5 HLTx. Nine patients had cystic fibrosis. One patient had end‐stage pulmonary disease secondary to chronic aspiration pneumonia and postadenovirus lung damage. Of 10 patients tested, 2 had severe GERD (Ft > 20%), 5 had moderate GERD (Ft 10–20%), 2 had mild GERD (Ft 5–10%), and 1 had no GERD. The only patient in this group with no GERD had a Nissen fundoplication pretransplant. All study patients were asymptomatic for GERD. All patients with episodes of rejection had moderate to severe GERD posttransplant. There was no association between severity of GERD and peak spirometry results posttransplant. Moderate to severe GERD is common following lung transplantation in children.
- 4 May 2005
- Published by Wiley in Pediatric Pulmonology
- Vol. 40 (1) , 68-71
High prevalence of gastroesophageal reflux in children after lung transplantation
Bronchiolitis obliterans and its clinical correlate bronchiolitis obliterans syndrome (BOS) are a major cause of morbidity and mortality following lung transplantation. Gastroesophageal reflux disease (GERD) may be a contributing factor for the development of BOS. Since 2002, all recipients of lung and heart‐lung transplantation at our institution have been routinely investigated for GERD. In this observational study, we report on the prevalence of GERD in this population, including all pediatric patients undergoing single (SLTx) or double (DLTx) lung transplantation or heart‐lung (HLTx) transplantation from January 2003–May 2004. GERD was assessed 3–6 months after transplantation by 24‐hr pH testing. The fraction time (Ft) with a pH < 4 within a 24‐hr period was recorded. Spirometry data, episodes of confirmed acute rejection, and demographic data were also collected. Ten transplant operations were performed: 4 DLTx, 1 SLTx, and 5 HLTx. Nine patients had cystic fibrosis. One patient had end‐stage pulmonary disease secondary to chronic aspiration pneumonia and postadenovirus lung damage. Of 10 patients tested, 2 had severe GERD (Ft > 20%), 5 had moderate GERD (Ft 10–20%), 2 had mild GERD (Ft 5–10%), and 1 had no GERD. The only patient in this group with no GERD had a Nissen fundoplication pretransplant. All study patients were asymptomatic for GERD. All patients with episodes of rejection had moderate to severe GERD posttransplant. There was no association between severity of GERD and peak spirometry results posttransplant. Moderate to severe GERD is common following lung transplantation in children.